Context Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CNTX

Based on 1 analyst offering 12 month price targets for Context Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell CNTX stock?

Based on 1 analyst offering ratings for Context Therapeutics Inc.
Strong Buy
0 analysts 0%
1 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CNTX stock forecasts and price targets.

CNTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 11%

1 of 1

CNTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMNN$1.30$15.00+1,053.85%Strong Buy
PSTV$0.27$4.25+1,485.82%Strong Buy

Context Therapeutics Stock Forecast FAQ

Is Context Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CNTX) stock is to Buy CNTX stock.

Out of 1 analyst, 0 (0%) are recommending CNTX as a Strong Buy, 1 (100%) are recommending CNTX as a Buy, 0 (0%) are recommending CNTX as a Hold, 0 (0%) are recommending CNTX as a Sell, and 0 (0%) are recommending CNTX as a Strong Sell.

If you're new to stock investing, here's how to buy Context Therapeutics stock.

What is CNTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CNTX price target, the average CNTX price target is $4.00, with the highest CNTX stock price forecast at $4.00 and the lowest CNTX stock price forecast at $4.00.

The Wall Street analyst predicted that Context Therapeutics's share price could reach $4.00 by Feb 7, 2024. The average Context Therapeutics stock price prediction forecasts a potential upside of 561.16% from the current CNTX share price of $0.61.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.